UNSPSC 85741970: Dilation of right fallopian tube via natural or artificial opening intraluminal device, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of right fallopian tube via natural or artificial opening intraluminal device, via natural or artificial opening endoscopic. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0U758DZ

UNSPSC 85741970 Dilation of right fallopian tube via natural or artificial opening intraluminal device, via natural or artificial opening endoscopic is a Commodity code that shows no relevant recent state and local procurement activity. The six most recent opportunities tagged under this code involve occupational medical surveillance, pharmacy benefit management, disability medical record review and independent medical examinations, surgical procedure carve-out networks, emergency and specialty healthcare for detained youth, and temporary health professional staffing — none of which relate to the code's nominal scope of a specific gynecological medical procedure. The code appears to be a medical taxonomy entry misapplied to administrative health services contracting, creating a fundamental mismatch between the code's clinical procedure definition and the purchasing activity it purports to classify.

State and local issuers using this code span county health systems, municipal retirement offices, state transportation departments, and county boards of commissioners across Arizona, California, Florida, and Washington. The actual work being solicited is health-program administration, occupational health compliance, medical staffing, and benefits management — not the procedure named in the code. Until state and local procurement offices reclassify these opportunities under more appropriate administrative or clinical services codes, this Commodity code will continue to report purchasing activity unrelated to its stated scope, limiting its utility for business development professionals evaluating opportunities in reproductive medicine or related clinical specialties.